공시 • Jan 22
Xebra Brands Ltd. announced that it expects to receive CAD 0.15 million in funding Xebra Brands Ltd. announced a non-brokered private placement that it will issue up to 3,000,000 units of the Company at a price of CAD 0.05 per unit for the gross proceeds of up to CAD 150,000 on January 22, 2025. Each Unit will consist of one common share of the Company and one-half of one Common Share purchase warrant. Each Warrant will entitle the holder thereof to acquire one Common Share at an exercise price of CAD 0.10 per Warrant Share at any time for a period of twenty-four months following the closing of the Offering. It is expected that the closing of the Offering will be on or about January 30, 2025, or such other date or dates that company may determine. The offering is subject to the receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange. Certain directors and officers of the Company are expected to participate in the Offering. 공시 • Jul 09
Xebra Brands Successfully Completes First Manufacturing Run for Elements Brand Ahead of Growing Demand in Mexico Xebra Brands Ltd. announced the successful completion of its first manufacturing run of its highly anticipated Elements line. This milestone represents a significant next step forward in Xebra Brands' commercialization efforts as the company prepares for initial distribution efforts in Mexico. The authorization for the importation, launch, and sale of the Elements Full Spectrum CBD Tinctures were granted to Elements Bioscience SAPI de C.V, a fully owned subsidiary of Xebra Brands Ltd, by Mexican regulatory authorities (COFEPRIS), and are expected to be sold in wellness and supplement stores, pharmacies and other retail channels which have accelerated their demand for new products. 공시 • Apr 17
Xebra Brands Ltd. Receives Second CBD Product Approval by COFEPRIS Xebra Brands Ltd. announced that it has received approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its second CBD product authorization to be sold in Mexico. This latest approval marks another milestone for Xebra Brands and highlights the Company's commitment to providing high-quality CBD products to consumers in Mexico. Building on the success of its first product approval in Mexico, Xebra Brands has obtained authorization for the transportation, launch, and sale of an additional 250mg Tincture, expanding its product offerings to meet the growing demand for premium CBD options in the region. Similar to its previously approved Tangerine Flavor CBD Tincture, this new product reflects Xebra's dedication to innovation, quality, and compliance within the CBD industry. Xebra Brands' 250mg Tincture is formulated with the same dedication to quality and purity as its previous offerings. Crafted with premium CBD extract, each batch of tincture undergoes thorough testing by third-party laboratories to ensure potency and consistency. This commitment to quality ensures that consumers in Mexico have access to trusted and reliable CBD products. With the approval of its second product by COFEPRIS, Xebra Brands reaffirms its position as a leader in the Mexican CBD industry. The company remains dedicated to meeting the evolving needs of consumers and providing natural wellness solutions that promote stress relief, relaxation, and overall well-being. 공시 • Apr 05
Xebra Brands Ltd. Submits Third Product Submission to Cofepris, Expanding Elements Brand Cbd Lineup Xebra Brands Ltd. announced the submission of its third product application for approval to COFEPRIS (Federal Commission for Protection Against Sanitary Risk) in Mexico for domestic production. This latest submission underscores Xebra's commitment to delivering high-quality CBD products to consumers across the country in a variety of formats. The newest addition to Xebra's Elements brand is a topical lotion meticulously crafted to provide targeted relief and nourishment for the skin, infused with premium CBD extract. Designed with precision and care, this topical lotion offers consumers a luxurious skincare experience backed by the trusted Elements brand. With the submission of the Elements Topical Lotion, Xebra now covers three major product categories in the Mexico CBD market, including topicals, tinctures, and capsules. The Company intends to continue applying for new product offerings to domestically produce products and expand into additional categories to meet the evolving needs of its consumers. Once approved by COFEPRIS, the Elements Topical Lotion will be available for purchase nationwide, providing consumers with a trusted, domestically produced solution for their skincare needs. 공시 • Mar 08
Xebra Brands Ltd. announced that it has received CAD 1 million in funding On March 7, 2024, Xebra Brands Ltd. closed the transaction. All of the units sold under the offering were purchased by David Ross Macias Diaz under a strategic investment agreement. Following the closing of the offering, David Ross Macias Diaz holds 18.04% and 30.56% of the common shares of the Company on a non-diluted basis and partially diluted basis, respectively. The offering is subject to the final acceptance of the CSE. 